IONS · Ionis Pharmaceuticals Inc

$57.24 +1.37 (+2.45%) At close · Aug 14

Market Cap

$9.51B

166.18M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$125,000,000

as of 2019-09-30 · not restated in filings since 2023-02-22

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$0	—	—	10-K, filed 2023-02-22
2021-12-31	$0	—	—	10-K, filed 2023-02-22
2020-12-31	$90,548,000	—	—	10-K, filed 2023-02-22
2019-12-31	$34,400,000	535,000	$64.30	10-K, filed 2023-02-22

2018-12-31	$0	—	—	10-K, filed 2021-02-24
2017-12-31	$0	—	—	10-K, filed 2020-03-02

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2021-12-31	$0 Δ	—	—	10-K, filed 2023-02-22
2021-09-30	$0 Δ	—	—	10-Q, filed 2021-11-03
2021-06-30	$0 Δ	—	—	10-Q, filed 2021-08-04
2021-03-31	$0	—	—	10-Q, filed 2021-05-05
2020-12-31	$0 Δ	—	—	10-K, filed 2023-02-22
2020-09-30	$0 Δ	—	—	10-Q, filed 2021-11-03
2020-06-30	$48,000 Δ	—	—	10-Q, filed 2021-08-04
2020-03-31	$90,500,000	1,500,000	$60.33	10-K, filed 2023-02-22
2019-12-31	$34,400,000	535,000	$64.30	10-K, filed 2020-03-02
2019-09-30	$0 Δ	—	—	10-Q, filed 2020-11-04
2019-06-30	$0 Δ	—	—	10-Q, filed 2020-08-05
2019-03-31	$0	—	—	10-Q, filed 2020-05-06

Key facts CIK 874015 CUSIP 462222100 13F (30d) 498 filings 470 filers Visit website Investor relations